Huge funding boost for chemistry firm could create up to 300 jobs in life sciences
Company will establish new global headquarters and research and development centre in Govan
Up to 300 jobs could be created at digital chemistry company following a multi-million investment deal aimed at enhancing Scotland’s reputation in the life sciences sector.
Scottish Enterprise and the UK government are supporting Glasgow-based digital chemistry company Chemify to accelerate its growth.
The public sector is contributing £22 million - £16 million from Scottish Enterprise and £6 million from the UK government - towards the company’s expansion, with Chemify contributing £67.9 million, taking the total company expansion project to £89.9 million.
Scottish Enterprise Chief Executive Adrian Gillespie said: “Chemify’s investment is a powerful vote of confidence in Scotland as a place to scale innovative deep-tech businesses. It will accelerate the company’s growth and create exciting opportunities across chemistry, advanced manufacturing and life sciences sectors.
“Having supported Chemify since 2023, I’m excited to see Lee and his team continue to choose Scotland for their expansion. It underlines the strength of Scotland’s innovation environment and the calibre of companies growing here.
“By backing ambitious, scaling businesses like Chemify, we’re helping world-leading Scottish science make a bigger impact globally.”
Founded in 2019 as a spinout from the University of Glasgow, Chemify works on pioneering the way new medicines and advanced materials are discovered.
It has developed technology fusing robotics and AI which automates the design, manufacture and testing of new chemical compounds, helping accelerate innovation across pharmaceutical and advanced materials industries with the potential to help researchers develop new treatments and advanced materials more quickly and at lower cost.
As part of Chemify’s expansion project, the company will establish its new global headquarters and research and development centre at the University of Glasgow's Health Innovation Hub in Govan, part of the Glasgow Riverside Innovation District.
This move will help anchor the company's future growth in Scotland while expanding its automated manufacturing operations in Glasgow. It is a direct example of the UK Government and Scottish Government supporting high-potential UK companies to grow, scale and remain in the UK, as committed to in Scotland’s Life Sciences Strategy and the UK Life Sciences Sector Plan.
The project will also establish Chemify as the first Chemistry Hyperscaler, increasing its capacity to rapidly design and make new compounds for partners, scale its technology globally and create opportunities across Scotland's life sciences, advanced manufacturing and technology sectors.
Professor Lee Cronin, founder and CEO of Chemify, said: “Just one year ago, our first Chemifarm in Glasgow proved that Chemputation works by grounding AI-enabled drug discovery in physical synthesis and improving the design and makeability of new molecules and materials.
“The additional funding will enable us to hyperscale chemistry, expand our next-generation Chemifarm and advance our Chemify Genesis system to vastly increase our capacity to create new molecules, materials and medicines and bespoke datasets.”
The expansion will increase Chemify's Scottish workforce from 152 employees to around 450 over the next three years, creating up to 300 highly skilled jobs and safeguarding a further 100 jobs.
Cabinet Secretary for Economy, Tourism and Transport Stephen Flynn said, "Scotland is a global centre for life sciences innovation and advanced manufacturing. This significant investment and creation of up to 300 highly skilled jobs at Chemify in Glasgow is a major boost for our economy and will help grow one of Scotland's most important and dynamic sectors.
“By supporting pioneering companies such as Chemify, we are reinforcing Scotland's position at the forefront of scientific discovery and next generation technologies, while helping deliver the ambitions set out in our Life Sciences Strategy, including growing the sector's contribution to £25 billion by 2035."
Comments
Want to join the conversation? Please or to comment on this article.